Ren Rongmei, Gao Miao, Fan Ping, Liu Xinghui, Liu Rui, Ma Lei, Chen Yihong, Liu Yu, Bai Huai
Laboratory of Genetic Disease and Perinatal Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Apr;32(2):245-9. doi: 10.3760/cma.j.issn.1003-9406.2015.02.021.
To investigate the relationship between two polymorphisms immediately upstream of the cyclooxygenase 2 (COX2) gene and preeclampsia in a South West Han Chinese population.
Blood samples from 205 patients with preeclampsia and 276 normal pregnant women as controls from Han Chinese in Chengdu area were analyzed by polymerase chain reaction-restriction fragment length polymorphisms.
G and A allele frequencies for -1195G>A site were 48.54% and 51.46% in the patient group, respectively, and 40.40% and 59.60% in the control group, respectively. G and C allele frequencies for -765G>C site were 94.15% and 5.85% in the case group, respectively, and 94.38% and 5.62% in the control group, respectively. The AA genotype and variant A allelic frequencies of the -1195G>A SNP were significantly lower in patients with preeclampsia than in the control group (P<0.05), and the odds ratio for the risk of preeclampsia was 0.665 (95% CI: 0.444-0.982) in women homozygous for the variant COX2 A allele ( x²=4.233, P=0.047). The genotype and allele frequencies of the -765G>C polymorphism in patients with preeclampsia and controls showed no significant differences (P>0.05). Additional subgroup analyses (mild vs severe preeclampsia) of the two polymorphisms failed to reveal significant correlation for either genotypic or allelic frequencies. Furthermore, there was no significant association between the polymorphisms and blood pressure levels in the patient or control groups.
COX2 -1195A homozygosity is associated with a decreased risk for preeclampsia in a South West Han Chinese population. On the other hand, the -765G>C polymorphism has no effect.
探讨环氧化酶2(COX2)基因上游紧邻的两个多态性位点与中国西南汉族人群子痫前期的关系。
采用聚合酶链反应-限制性片段长度多态性方法,对成都地区205例子痫前期患者及276例正常孕妇(作为对照)的血样进行分析。
-1195G>A位点的G和A等位基因频率在患者组分别为48.54%和51.46%,在对照组分别为40.40%和59.60%。-765G>C位点的G和C等位基因频率在病例组分别为94.15%和5.85%,在对照组分别为94.38%和5.62%。子痫前期患者中-1195G>A单核苷酸多态性(SNP)的AA基因型和变异A等位基因频率显著低于对照组(P<0.05),COX2变异A等位基因纯合子女性患子痫前期风险的比值比为0.665(95%可信区间:0.444 - 0.982)(χ² = 4.233,P = 0.047)。子痫前期患者与对照组中-765G>C多态性的基因型和等位基因频率无显著差异(P>0.05)。对这两个多态性位点进行的额外亚组分析(轻度子痫前期与重度子痫前期)未发现基因型或等位基因频率有显著相关性。此外,患者组或对照组中多态性与血压水平之间无显著关联。
在中国西南汉族人群中,COX2 -1195A纯合性与子痫前期风险降低相关。另一方面,-765G>C多态性无影响。